Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.
Toshifumi TadaTakashi KumadaAtsushi HiraokaKojiro MichitakaMasanori AtsukawaMasashi HirookaKunihiko TsujiToru IshikawaKoichi TakaguchiKazuya KariyamaEi ItobayashiKazuto TajiriNoritomo ShimadaHiroshi ShibataHironori OchiHidenori ToyodaKazuhiro NousoAkemi TsutsuiTakuya NaganoNorio ItokawaKorenobu HayamaMichitaka ImaiKouji JokoYohei KoizumiYoichi HiasaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2019)
Lenvatinib can be used safely and efficaciously regardless of age in patients with HCC.
Keyphrases